Stock Alert: CareDx Touches New High On Q3 Revenue Growth

By RTTNews Staff Writer   ✉   | Published:

Shares of precision medicine solutions company CareDx, Inc (CDNA) are rising more than 15% Thursday morning after the company reported preliminary third-quarter revenue, 57% more than last year.

The stock touched a new high of $51.70 today morning.

CareDx expects third-quarter revenue to be about $53.0 million, an increase of 57% compared with $33.8 million last year. Analysts polled by Thomson Reuters expect the company to report revenue of $44.68 million for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walt Disney Co. is reorganizing its media and entertainment businesses aiming to accelerate its direct-to-consumer or DTC strategy following the significant success of its streaming service Disney+. In a statement, the company stated that its media and entertainment businesses will be separated into creative engines, as well as Media and Entertainment Distribution Group. Johnson & Johnson (JNJ) has paused the phase III study of its COVID-19 vaccine candidate, JNJ-78436735, due to an unexplained illness in a study participant, Stat News reported, citing a document sent to outside researchers running the 60,000-patient clinical trial. Twitter has taken additional steps to prevent any manipulation or interference in the upcoming U.S. Elections or other civic processes through misleading Tweets. It announced significant product and enforcement updates to enable the smooth conduct of the democratic process. The social media platform has recently expanded its civic integrity policy to address misleading information.